ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

YS YS Biopharma Company Ltd

0.952
0.002 (0.21%)
09 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
YS Biopharma Company Ltd YS NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.002 0.21% 0.952 18:40:36
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.94 0.94 1.02 0.952 0.95
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
07/5/202415:20PRNUSYS Biopharma to Hold Extraordinary General Meeting on May..
29/4/202407:00PRNUSYS Biopharma Receives Additional 180 Day Extension by Nasdaq..
19/4/202406:00PRNUSYS Biopharma Announces Unaudited Financial Results for the..
18/4/202407:00PRNUSYS Biopharma Granted Phase I Clinical Trial License of..
16/4/202407:00PRNUSYS Biopharma to Report First Nine Months of Fiscal Year 2024..
09/4/202407:00PRNUSYS Biopharma Announces Positive Interim Results of Pivotal..
03/4/202407:00PRNUSYS Biopharma Announces Full Repayment of US$40,000,000 Loan..
05/3/202407:00PRNUSYS Biopharma Announces Board Changes and Strategic..
22/2/202416:00PRNUSYS Biopharma Announces Results of Extraordinary General..
18/2/202403:30PRNUS/C O R R E C T I O N -- YS Biopharma Co., Ltd./
16/2/202419:20PRNUSYS Biopharma Announces Results of Extraordinary General..
14/2/202407:00PRNUSYS Biopharma to Hold an Extraordinary General Meeting on..
14/2/202406:50PRNUSYS Biopharma Announces Appointment of New Directors
12/2/202407:50PRNUSYS Biopharma Responds to a Notice of Extraordinary General..
09/2/202405:30PRNUSYS Biopharma Announces US$40 Million Private Placement..
08/2/202417:10PRNUSShareholders of YS Biopharma Announce an Extraordinary..
22/1/202416:00PRNUSYS Biopharma Announces Unaudited Financial Results for the..
08/1/202407:00PRNUSYS Biopharma Announces Changes to its Board Committees
20/12/202315:30PRNUSYS Biopharma Responds to Unauthorized Press Release..
20/12/202307:56PRNUSYS Biopharma Co., Ltd. to Hold Extraordinary General Meeting..
14/11/202307:30PRNUSNoble Capital Markets Initiates Coverage on YS Biopharma..
31/10/202307:30PRNUSYS Biopharma Announces Completion of Subject Enrollment in..
26/10/202307:30PRNUSYS Biopharma Announces Receipt of Nasdaq Notice
26/9/202307:30PRNUSYS Biopharma Announces First Subject Enrollment in Pivotal..
15/9/202307:30PRNUSYS Biopharma Granted Patent in the U.S. for Immunotherapy..
05/9/202307:30PRNUSYS Biopharma to Participate in Participate in Citi's 18th..
24/8/202315:15PRNUSYS Biopharma Announces Purchase of Shares by Company..
15/8/202316:00PRNUSYS Biopharma Announces Unaudited Financial Results for the..
26/7/202316:00PRNUSYS Biopharma Announces Financial Results for Fiscal Year..
21/7/202315:30PRNUSYS Biopharma to Report Financial Results for Fiscal Year..
01/6/202307:30PRNUSYS Biopharma's PIKA Rabies Vaccine Receives Phase 3 Clinical..
18/5/202307:25PRNUSYS Biopharma to Participate in the Virtual Benchmark..
16/5/202306:00PRNUSYS Biopharma's PIKA Rabies Vaccine Receives Phase 3 Clinical..

Su Consulta Reciente

Delayed Upgrade Clock